Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Gene Variant Reduced Benefit of Pediatric Asthma Drug

A study indicates pediatric asthma patients with a common gene variant may experience diminished response to mepolizumab during viral infections.

Chronic Pulmonary Disorders

Salt Aerosol May Counter Increased Cough Sensitivity from Dry Air

Exposure to very dry air collapses airway mucus, but an inhaled magnesium mist could help protect the respiratory tract.

Chronic Pulmonary Disorders

Semaglutide Tied to Fewer Asthma, COPD Exacerbations

The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.

Asthma

California to Send Free Asthma Inhalers to All Public Schools

California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.

COPD

Insurance Barriers Limit Pulmonary Rehab Access

Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.

Cystic fibrosis

Wearable Sweat Test Stickers for Cystic Fibrosis

Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.

Pulmonary Fibrosis

Lung Health Navigators for Pulmonary Fibrosis Patients

The American Lung Association provides personalized guidance from RTs and nurses to help pulmonary fibrosis patients manage lung disease.

Allergies

How Hurricane Flooding Affects Respiratory Symptoms

Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.

Other Chronic Diseases

Brinsupri/Brensocatib Approved for Bronchiectasis in Japan

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.